Pharvaris PHVS
NASDAQ PHVS
$31.31 +0.41 (+1.33%)
As of: Oct 21, 2026 · 11:13 AM EDT

Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023)

Updated

Pharvaris (PHVS) posted Other Non-Current Assets of $667,960 for Q4 2023, up 12.4% from $594,385 a year earlier.

Analysis

Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023) Analysis & Trends

At the end of FY2023, Pharvaris' Other Non-Current Assets came in at $671,547, up 9.4% from FY2022.

  • Annual Other Non-Current Assets shows a three-year compound annual growth rate of -21.4% (FY2020 to FY2023).
  • In prior years, Pharvaris' Other Non-Current Assets was $614,023 in FY2022, $6,744 in FY2021 (-99.5%) and $1.38 million in FY2020.
  • Quarterly Other Non-Current Assets has run from a low of $6,519 in Q4 2021 to a high of $1.45 million in Q4 2020 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.26 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 614.28 Bn 532.81 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.23 Bn 476.34 Bn 12.70 Bn 10.73 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.22 Bn 262.21 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.55 Bn 235.23 Bn 12.86 Bn -
7 Amgen 235.92 Bn 191.31 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 190.78 Bn 164.98 Bn 6.22 Bn 4.75 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn 9.94 Bn
10 Pharvaris 1.85 Bn 476.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 687,129.93
Jun 30, 2023 1.03 Mn
Dec 31, 2022 621,083.76
Dec 31, 2021 6,454.13
Dec 31, 2020 1.49 Mn
API Access

Pharvaris Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=PHVS&period=max&api_key=YOUR_API_KEY